These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11526091)

  • 21. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
    Khoury SJ; Hancock WW; Weiner HL
    J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Xu L; Huang Y; Yang J; Van Der Meide PH; Levi M; Wahren B; Link H; Xiao B
    Clin Exp Immunol; 1999 Oct; 118(1):115-21. PubMed ID: 10540168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
    Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
    J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta.
    Issazadeh S; Lorentzen JC; Mustafa MI; Höjeberg B; Müssener A; Olsson T
    J Neuroimmunol; 1996 Sep; 69(1-2):103-15. PubMed ID: 8823381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit.
    Chang JT; Segal BM; Nakanishi K; Okamura H; Shevach EM
    Eur J Immunol; 2000 Apr; 30(4):1113-9. PubMed ID: 10760800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
    Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
    J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
    Abdin AA; Hasby EA
    Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4.
    Sedgwick JD; Mason DW
    J Neuroimmunol; 1986 Dec; 13(2):217-32. PubMed ID: 3097071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine expression by inflammatory cells obtained from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis induced by inoculation with myelin basic protein and adjuvants.
    McCombe PA; Nickson I; Pender MP
    J Neuroimmunol; 1998 Aug; 88(1-2):30-8. PubMed ID: 9688321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
    Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
    Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of experimental autoimmune encephalomyelitis (EAE): differential effect of anti-IL-2 receptor antibody therapy on actively induced and T-line mediated EAE of the Lewis rat.
    Engelhardt B; Diamantstein T; Wekerle H
    J Autoimmun; 1989 Feb; 2(1):61-73. PubMed ID: 2473763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic influence on disease course and cytokine response in relapsing experimental allergic encephalomyelitis.
    Kjellén P; Issazadeh S; Olsson T; Holmdahl R
    Int Immunol; 1998 Mar; 10(3):333-40. PubMed ID: 9576621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DAB
    Bhopale MK; Hilliard B; Constantinescu CS; Phillips SM; Rostami A
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):318-329. PubMed ID: 28929835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat.
    Hickey WF; Cohen JA; Burns JB
    Cell Immunol; 1987 Oct; 109(2):272-81. PubMed ID: 2444345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP; Piddlesden S; Morgan BP; Reynolds R
    Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
    Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
    J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.